Therapeutics Acquisition

$13.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-0.74%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell RACA and other stocks, options, and ETFs commission-free!

About RACA

Therapeutics Acquisition Corp. Class A Common Stock, also called Therapeutics Acquisition, is a blank check company with a purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Read More The company was founded by Peter Kolchinsky and Matthew Hammond on April 15, 2020 and is headquartered in Boston, MA. The listed name for RACA is Therapeutics Acquisition Corp. Class A Common Stock.

Employees
Headquarters
Boston, Massachusetts
Founded
Market Cap
Price-Earnings Ratio
Dividend Yield
Average Volume
5.74K
High Today
$13.40
Low Today
$13.20
Open Price
$13.29
Volume
9.45K
52 Week High
$21.44
52 Week Low
$11.11

Collections

RACA Earnings

-$0.01
-$0.01
-$0.00
$0.00
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 10, Pre-Market

You May Also Like